Answers are grounded in this paper and cite their sources.
Isotactic polypropylene (iPP) and iron oxide (Fe 3 O 4 ) nanocomposites were mixed by masterbatch blending technique in a single screw extruder machine. The concentrations of Fe 3 O 4 in the iPP/Fe 3 O 4 nanocomposites were 0.5, 1, 2, and 5% by weight. The influence of Fe 3 O 4 nanoparticles on the effectiveness of nucleation, morphology, mode of crystallization, and crystallinity of iPP were studied by differential scanning calorimetry (DSC) and polarized light microscopy (PLM). The introduction of Fe 3 O 4 nanoparticles in the iPP matrix inhibited the formation of β crystals, and caused a shift in the melting point to higher values. The magnitude of the shift was up to 20–21°C which indicates that using the masterbatch technique leads to an enhancement of the dispersion process of the Fe 3 O 4 nanoparticle and the formation of less agglomerates in the iPP/Fe 3 O 4 nanocomposites. The percentage crystallinity, X c , increased at the low cooling rates of 1 and 2°C/min. At higher cooling rates of 5, 10, and 20°C/min, the masterbatch technique produced nanocomposites of X c with nonuniform trends. The overall crystallization rate enhancement for the iPP/Fe 3 O 4 nanocomposites is attributed to the presence of Fe 3 O 4 nanoparticles as a nucleating agent which have no significant effect on the growth rate of iPP crystals.
No takes yet. Share an insight, caveat, or question.
Mubarak et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: